UK Markets closed

Innate Pharma S.A. (IPHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.3400-0.4000 (-8.44%)
At close: 04:00PM EST
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 0.11
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 311.9500
52-week low 33.0200
50-day moving average 35.5946
200-day moving average 34.4878

Share statistics

Avg vol (3-month) 31.39M
Avg vol (10-day) 377.13k
Shares outstanding 579.01M
Implied shares outstanding 6N/A
Float 851.13M
% held by insiders 11.55%
% held by institutions 10.38%
Shares short (14 Jul 2021) 412.79k
Short ratio (14 Jul 2021) 40.4
Short % of float (14 Jul 2021) 4N/A
Short % of shares outstanding (14 Jul 2021) 40.02%
Shares short (prior month 14 Jun 2021) 416.43k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin -90.82%
Operating margin (ttm)-26.33%

Management effectiveness

Return on assets (ttm)-3.27%
Return on equity (ttm)-34.27%

Income statement

Revenue (ttm)70.45M
Revenue per share (ttm)0.89
Quarterly revenue growth (yoy)26.40%
Gross profit (ttm)11.84M
EBITDA -6.32M
Net income avi to common (ttm)-63.98M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)151.64M
Total cash per share (mrq)1.92
Total debt (mrq)19.09M
Total debt/equity (mrq)12.24
Current ratio (mrq)3.81
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-51.77M
Levered free cash flow (ttm)-86.76M